Advertisement
UK markets closed

  • FTSE 100

    8,139.83
    +60.97 (+0.75%)
     

  • FTSE 250

    19,824.16
    +222.18 (+1.13%)
     

  • AIM

    755.28
    +2.16 (+0.29%)
     

  • GBP/EUR

    1.1677
    +0.0021 (+0.18%)
     

  • GBP/USD

    1.2502
    -0.0009 (-0.07%)
     

  • Bitcoin GBP

    51,189.17
    -508.86 (-0.98%)
     

  • CMC Crypto 200

    1,333.38
    -63.16 (-4.52%)
     

  • S&P 500

    5,109.10
    +60.68 (+1.20%)
     

  • DOW

    38,291.35
    +205.55 (+0.54%)
     

  • CRUDE OIL

    83.74
    +0.17 (+0.20%)
     

  • GOLD FUTURES

    2,350.40
    +7.90 (+0.34%)
     

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     

  • DAX

    18,161.01
    +243.73 (+1.36%)
     

  • CAC 40

    8,088.24
    +71.59 (+0.89%)
     
PROPERTY:

9 luxury homes to consider if money is no object

Ever thought about what a multimillion pound budget would buy you?

These 3 Stocks Will Make You A Fortune If They Succeed

Jason Hawthorne, The Motley Fool
·5-min read
These 3 Stocks Will Make You A Fortune If They Succeed

Unfortunately, capturing that type of gain typically means investing while the company is still small and its outcome is uncertain. Trillium Therapeutics (NASDAQ: TRIL), Vaxart (NASDAQ: VXRT), and Twist Biosciences (NASDAQ: TWST) have ambitions so big, they could produce these life-changing returns from the big-risk, big-reward portion of a diversified portfolio. Jan Skvarka, who Trillium introduced as CEO near the end of 2019, has said the company's long-term goal is to challenge chemotherapy.

Continue reading